Search

UCB SA

Geschlossen

BrancheGesundheitswesen

202.6 -0.1

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

200.6

Max

204.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

28M

1.1B

Verkäufe

16M

4.3B

KGV

Branchendurchschnitt

18.561

56.597

EPS

5.7

Dividendenrendite

0.69

Gewinnspanne

26.019

Angestellte

9,000

EBITDA

587M

1.4B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+19.23% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.69%

2.18%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-6.7B

40B

Vorheriger Eröffnungskurs

202.7

Vorheriger Schlusskurs

202.6

Nachrichtenstimmung

By Acuity

100%

0%

322 / 339 Ranking in Healthcare

UCB SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Sept. 2026, 23:51 UTC

News

The Nikkei 225 Index is lower in after-market hours, pressured by rising oil prices above $100 and a recent European Central Bank rate hike.

10. Sept. 2026, 23:46 UTC

Correlated Moves
News

Valero Energy Corp is trading higher in after-market hours following a Power Inflow alert, reflecting increased buying interest among investors.

10. Sept. 2026, 23:41 UTC

Event
News

AbbVie Inc declared a quarterly dividend of $1.73, with a record date of October 15, 2026. Shares are higher in after-hours trading.

10. Sept. 2026, 23:31 UTC

Correlated Moves
Macro Event
News

The USD/THB exchange rate is gaining during Thursday's session, supported by recent macroeconomic data, despite a lack of typical volatility in the market.

10. Sept. 2026, 23:26 UTC

News

Constellation Brands will report second-quarter results on October 6. In after-market trading, shares are higher, though still near the lower end of their one-month range.

10. Sept. 2026, 23:16 UTC

News

Artisan Partners Asset Management reports $183.5 billion in AUM as of August 31. Shares are trading lower in after-market hours following a client restructuring.

10. Sept. 2026, 23:16 UTC

News

Accenture PLC secured a $480.37 million Army contract for the Joint Enterprise Task Management System, boosting shares in after-market trading.

10. Sept. 2026, 23:16 UTC

News

Tencent Music Entertainment closed a $1 billion notes offering, with shares trading higher in after-market hours. Proceeds will support corporate purposes and debt refinancing.

10. Sept. 2026, 23:11 UTC

Correlated Moves
News
Macro Event

The USD/SGD exchange rate is trading higher amid recent macroeconomic data, including a rise in the US Producer Price Index and Initial Jobless Claims.

10. Sept. 2026, 23:06 UTC

News
Social Media

Microsoft plans to expand data center capacity to over 38 gigawatts by 2032. Shares are lower in after-market trading, continuing recent declines.

10. Sept. 2026, 23:06 UTC

News

Wedbush initiated coverage on Datadog with an Outperform rating and a $275 price target. Shares are higher in after-market trading, closing at $225.27.

10. Sept. 2026, 23:06 UTC

News

HP Inc. shares are higher in after-market trading following RBC Capital's initiation of coverage with a Sector Perform rating and a $33.00 price target.

10. Sept. 2026, 23:06 UTC

Correlated Moves
News
Macro Event

The USD/ZAR exchange rate is higher today, supported by US Producer Price Index data and Initial Jobless Claims that indicate labor market resilience.

10. Sept. 2026, 23:06 UTC

Correlated Moves
News

Autodesk has entered an agreement for $1 billion in senior notes to refinance debt. Shares are trading higher in after-market hours following the announcement.

10. Sept. 2026, 23:02 UTC

News

Visa Inc shares are lower in after-market hours, despite launching an onchain lending initiative with Credit Coop that financed $2.5 billion.

10. Sept. 2026, 23:02 UTC

News
Social Media

GameStop Corp shares rose in after-hours trading following CEO Ryan Cohen's purchase of 1 million shares for about $20.4 million, boosting his ownership stake.

10. Sept. 2026, 23:02 UTC

News
Event
Social Media

Oracle Corp reported Q1 earnings of $1.92, exceeding estimates, and raised its fiscal 2027 EPS guidance to $8.10. Shares rose in after-hours trading.

10. Sept. 2026, 23:02 UTC

News
Social Media

Adobe shares declined in after-market trading following Q3 results. While revenue of $6.76 billion surpassed expectations, fourth-quarter guidance fell short of consensus.

10. Sept. 2026, 23:01 UTC

Social Media
News

ACV Auctions shares rise sharply in after-hours trading on reports of Copart's nearing $1.9 billion acquisition deal at $10.50 per share.

10. Sept. 2026, 23:01 UTC

Correlated Moves
News
Macro Event

The USD/HUF exchange rate is higher, supported by recent macroeconomic data and a correlated rise in USD/CHF. Earlier, it peaked with a notable gain.

10. Sept. 2026, 23:01 UTC

Event
Social Media
News

RH shares rose in after-market trading after reporting fiscal Q2 results, including adjusted EPS of $2.70, significantly surpassing estimates of $1.78.

10. Sept. 2026, 23:01 UTC

Correlated Moves
News
Macro Event

The USD/SEK exchange rate is rising, supported by US PPI data and jobless claims indicating a resilient labor market. The pair remains above its 20-day moving average.

10. Sept. 2026, 23:01 UTC

Correlated Moves
News

Comfort Systems USA Inc. is higher in after-market trading, reflecting strong five-year performance with a market cap of $55.99 billion. IES Holdings Inc. also rose.

10. Sept. 2026, 23:01 UTC

Correlated Moves
News
Social Media

Robinhood Markets Inc shares declined in after-market trading following mixed August operating data, including a drop in net deposits and securities lending revenue.

10. Sept. 2026, 23:01 UTC

News
Social Media

Celsius Holdings shares rose in after-hours trading after CEO John Fieldly bought 18,000 shares for $493.8K, boosting his total ownership to 956,000 shares.

10. Sept. 2026, 23:01 UTC

Correlated Moves
News
Macro Event

The USD/NOK exchange rate is rising, supported by positive US PPI data and resilient jobless claims figures. Broader market trends also favor the currency pair.

10. Sept. 2026, 23:01 UTC

News
Social Media

Copart Inc will acquire ACV Auctions for $10.50 per share, valuing the deal at $1.9 billion. Shares rose significantly in after-market trading.

10. Sept. 2026, 22:51 UTC

News

Wix.Com Ltd shares are lower in after-market hours following a class action lawsuit alleging false statements about its AI product offerings and financial disclosures.

10. Sept. 2026, 22:46 UTC

News

Curtiss-Wright Corp lowers shares in after-market hours despite announcing a $700 million share repurchase authorization and a quarterly dividend of $0.26 per share.

10. Sept. 2026, 22:41 UTC

News

Thor Industries shares rise sharply in after-market trading following leadership changes aimed at restructuring North American RV operations to enhance efficiency and cost savings.

Peer-Vergleich

Kursveränderung

UCB SA Prognose

Kursziel

By TipRanks

19.23% Vorteil

12-Monats-Prognose

Durchschnitt 94.86 EUR  19.23%

Hoch 125 EUR

Tief 74 EUR

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für UCB SA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

7 ratings

4

Buy

1

Halten

2

Sell

Stimmung

By Acuity

322 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über UCB SA

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
help-icon Live chat